H5N1 claims first African victim:
This article was originally published in Clinica
Executive Summary
The Egyptian ministry of health yesterday confirmed the country's first case of human infection with the H5N1 virus, making it also the first avian flu death in Africa. The patient, a 30-year-old woman from the Qaliubiya governorate, near Cairo, developed symptoms in early March and died within 24 hours of being hospitalised. Testing was conducted by the Cairo-based US Naval Medical Research Unit, NAMRU-3. Diagnostic verification and further analysis is being conducted by a WHO collaborating laboratory. The news follows World Health Organization warnings to health authorities across the continent to rapidly develop surveillance systems and healthcare services.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.